First-Line Management of Follicular Lymphoma

被引：0

作者：

Marcus, Robert ^{[1
]}

机构：

[1] HCA Haematol, London W1G 6AF, England

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷

关键词：

Watch and wait; Radiotherapy; Chemo-immunotherapy; Novel agents; ADVANCED-STAGE; R-CVP; SIGNIFICANTLY IMPROVES; TRIAL; RITUXIMAB; CYCLOPHOSPHAMIDE; CHEMOTHERAPY; VINCRISTINE; INTERFERON; PREDNISONE;

D O I：

10.1016/j.clml.2018.06.064

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

FR-S22-EB-

引用

页码：S83 / S85

页数：3

共 15 条

[1] Rituximab versus a watch-and-wait approach in patients with advanced- stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial [J].

Ardeshna, Kirit M. ;

Qian, Wendi ;

Smith, Paul ;

Braganca, Nivette ;

Lowry, Lisa ;

Patrick, Pip ;

Warden, June ;

Stevens, Lindsey ;

Pocock, Christopher F. E. ;

Miall, Fiona ;

Cunningham, David ;

Davies, John ;

Jack, Andrew ;

Stephens, Richard ;

Walewski, Jan ;

Ferhanoglu, Burhan ;

Bradstock, Ken ;

Linch, David C. .

LANCET ONCOLOGY, 2014, 15 (04) :424-435

[2] Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial [J].

Ardeshna, KM ;

Smith, P ;

Norton, A ;

Hancock, BW ;

Hoskin, PJ ;

MacLennan, KA ;

Marcus, RE ;

Jelliffe, A ;

Hudson, GV ;

Linch, DC .

LANCET, 2003, 362 (9383) :516-522

[3]

Bentur Ohad S., 2017, LEUKEMIA LYMPHOMA, V59, P1163

[4] Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma [J].

Cencini, Emanuele ;

Puccini, Benedetta ;

Rigacci, Luigi ;

Fabbri, Alberto ;

Kovalchuk, Sofia ;

Mannelli, Lara ;

Benelli, Gemma ;

Carfagno, Tommaso ;

Simontacchi, Gabriele ;

Bocchia, Monica ;

Bosi, Alberto .

LEUKEMIA & LYMPHOMA, 2018, 59 (06) :1420-1426

[5] Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma:: An East German Study Group hematology and oncology study [J].

Herold, Michael ;

Haas, Antje ;

Srock, Stefanie ;

Neser, Sabine ;

Al-Ali, Kathrin Haifa ;

Neubauer, Andreas ;

Doelken, Gottfried ;

Naumann, Ralph ;

Knauf, Wolfgang ;

Freund, Mathias ;

Rohrberg, Robert ;

Hoeffken, Klaus ;

Franke, Astrid ;

Ittel, Thomas ;

Kettner, Erika ;

Haak, Ursula ;

Mey, Ulrich ;

Klinkenstein, Christian ;

Assmann, Michael ;

von Gruenhagen, Ullrich .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) :1986-1992

[6] Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone:: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group [J].

Hiddemann, W ;

Kneba, M ;

Dreyling, M ;

Schmitz, N ;

Lengfelder, E ;

Schmits, R ;

Reiser, M ;

Metzner, B ;

Harder, H ;

Hegewisch-Becker, S ;

Fischer, T ;

Kropff, M ;

Reis, HE ;

Freund, M ;

Wörmann, B ;

Fuchs, R ;

Planker, M ;

Schimke, J ;

Eimermacher, H ;

Trümper, L ;

Aldaoud, A ;

Parwaresch, R ;

Unterhalt, M .

BLOOD, 2005, 106 (12) :3725-3732

[7] 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non- inferiority trial [J].

Hoskin, Peter J. ;

Kirkwood, Amy A. ;

Popova, Bilyana ;

Smith, Paul ;

Robinson, Martin ;

Gallop-Evans, Eve ;

Coltart, Stewart ;

Illidge, Timothy ;

Madhavan, Krishnaswamy ;

Brammer, Caroline ;

Diez, Patricia ;

Jack, Andrew ;

Syndikus, Isabel .

LANCET ONCOLOGY, 2014, 15 (04) :457-463

[8] Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma [J].

Luminari, Stefano ;

Ferrari, Angela ;

Manni, Martina ;

Dondi, Alessandra ;

Chiarenza, Annalisa ;

Merli, Francesco ;

Rusconi, Chiara ;

Tarantino, Vittoria ;

Tucci, Alessandra ;

Vitolo, Umberto ;

Kovalchuk, Sofia ;

Angelucci, Emanuele ;

Pulsoni, Alessandro ;

Arcaini, Luca ;

Angrilli, Francesco ;

Gaidano, Gianluca ;

Stelitano, Caterina ;

Bertoldero, Giovanni ;

Cascavilla, Nicola ;

Salvi, Flavia ;

Ferreri, Andres J. M. ;

Vallisa, Daniele ;

Marcheselli, Luigi ;

Federico, Massimo .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (07) :689-+

[9] Treatment with 6 Cycles of CVP or R-CVP after Involved Field Radiation Therapy (IFRT) Significantly Improves Progression-free Survival Compared to IFRT alone in Stage I-II Low Grade Follicular Lymphoma: Results of an International Randomized Trial [J].

MacManus, M. P. ;

Fisher, R. ;

Roos, D. ;

O'Brien, P. ;

Macann, A. M. J. ;

Christie, D. ;

Tsang, R. W. ;

Davis, S. R. ;

Joseph, D. J. ;

McClure, B. ;

Seymour, J. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (05) :938-938

[10] Obinutuzumab for the First-Line Treatment of Follicular Lymphoma [J].

Marcus, R. ;

Davies, A. ;

Ando, K. ;

Klapper, W. ;

Opat, S. ;

Owen, C. ;

Phillips, E. ;

Sangha, R. ;

Schlag, R. ;

Seymour, J. F. ;

Townsend, W. ;

Trneny, M. ;

Wenger, M. ;

Fingerle-Rowson, G. ;

Rufibach, K. ;

Moore, T. ;

Herold, M. ;

Hiddemann, W. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14) :1331-1344

← 1 2 →